InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: ClosetInvestor post# 162971

Sunday, 05/02/2021 11:50:04 AM

Sunday, May 02, 2021 11:50:04 AM

Post# of 233121
Ibalizumab was approved with 40 patients and 43% efficacy in 25 weeks study IV Infusion ..with some side effects ..
one or two years ago

Cydy finished in 2018 , with 52 patients 25 weeks study SC injection , and no serious side effects ..

I remember facts ,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News